Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-4-6
pubmed:abstractText
The aim of this study is to compare the antiemetic efficacy and tolerability of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed emesis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-10477166, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-10690042, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-10705879, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-1397053, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-1435844, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-1467456, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-1627406, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-2642536, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-6681766, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-7690681, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-7787130, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-8141114, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-8164028, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-8673351, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-8708713, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-9506240, http://linkedlifedata.com/resource/pubmed/commentcorrection/20368831-9512674
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Dec
pubmed:issn
2005-9256
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
372-6
pubmed:dateRevised
2010-9-30
pubmed:year
2004
pubmed:articleTitle
Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients.
pubmed:affiliation
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
pubmed:publicationType
Journal Article